Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Childhood B-acute lymphoblastic leukemia: a genetic update
Jennifer S. Woo, Michael O. Alberti, Carlos A Tirado
Experimental Hematology and Oncology (2014) Vol. 3, Iss. 1
Open Access | Times Cited: 123

Showing 1-25 of 123 citing articles:

Leucemia linfoide aguda e seus principais conceitos
Matheus Santos Cavalcante, Isabelly Sabrina Santana Rosa, Fernanda Valeria Torres
Revista Científica FAEMA (2017) Vol. 8, Iss. 2, pp. 151-151
Open Access | Times Cited: 72
circRNA circAF4 functions as an oncogene to regulate MLL-AF4 fusion protein expression and inhibit MLL leukemia progression
Wei Huang, Ke Fang, Tian-Qi Chen, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 62
Single-cell analysis of childhood leukemia reveals a link between developmental states and ribosomal protein expression as a source of intra-individual heterogeneity
Maxime Caron, Pascal St-Onge, Thomas Sontag, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 51
Natural Killer Cell-Mediated Immunotherapy for Leukemia
Michaela Allison, Joel Mathews, Taylor Gilliland, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 843-843
Open Access | Times Cited: 37
Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent Akt reactivation
Carolina Simioni, Alice Cani, Alberto M. Martelli, et al.
Oncotarget (2014) Vol. 5, Iss. 20, pp. 10034-10047
Open Access | Times Cited: 60
Nanomedicine approaches in acute lymphoblastic leukemia
Andra-Sorina Tatar, Timea Nagy-Simon, Ciprian Tomuleasa, et al.
Journal of Controlled Release (2016) Vol. 238, pp. 123-138
Closed Access | Times Cited: 58
Epigenetic balance ensures mechanistic control of MLL amplification and rearrangement
Zach H. Gray, Damayanti Chakraborty, Reuben R. Duttweiler, et al.
Cell (2023) Vol. 186, Iss. 21, pp. 4528-4545.e18
Open Access | Times Cited: 14
Genome-Wide DNA Copy Number Analysis of Acute Lymphoblastic Leukemia Identifies New Genetic Markers Associated with Clinical Outcome
Maribel Forero‐Castro, Cristina Robledo, Rocí­o Benito, et al.
PLoS ONE (2016) Vol. 11, Iss. 2, pp. e0148972-e0148972
Open Access | Times Cited: 44
Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia
Maribel Forero‐Castro, Cristina Robledo, Rocí­o Benito, et al.
British Journal of Cancer (2017) Vol. 117, Iss. 2, pp. 256-265
Open Access | Times Cited: 43
Identification and Staging of B-Cell Acute Lymphoblastic Leukemia Using Quantitative Phase Imaging and Machine Learning
Vinay Ayyappan, Alex Chang, Chi Zhang, et al.
ACS Sensors (2020) Vol. 5, Iss. 10, pp. 3281-3289
Closed Access | Times Cited: 35
Raman and quantitative phase imaging allow morpho-molecular recognition of malignancy and stages of B-cell acute lymphoblastic leukemia
Santosh Kumar Paidi, Piyush Raj, Rosalie Bordett, et al.
Biosensors and Bioelectronics (2021) Vol. 190, pp. 113403-113403
Open Access | Times Cited: 32
Hyaluronan-Mediated Motility Receptor (HMMR) Overexpression Is Correlated with Poor Survival in Patients with B-ALL
Josselen Carina Ramírez‐Chiquito, Vanessa Villegas-Ruíz, Isabel Vera, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 744-744
Open Access
Simultaneous B and T cell acute lymphoblastic leukemias in zebrafish driven by transgenic MYC: implications for oncogenesis and lymphopoiesis
Chiara Borga, Gilseung Park, Clay A. Foster, et al.
Leukemia (2018) Vol. 33, Iss. 2, pp. 333-347
Open Access | Times Cited: 37
A novel and easy FxCycle™ violet based flow cytometric method for simultaneous assessment of DNA ploidy and six‐color immunophenotyping
Prashant Tembhare, Yajamanam Badrinath, Sitaram Ghogale, et al.
Cytometry Part A (2015) Vol. 89, Iss. 3, pp. 281-291
Open Access | Times Cited: 35
SPECTRUM AND IMMUNOPHENOTYPIC PROFILE OF ACUTE LEUKEMIA: A TERTIARY CENTER FLOW CYTOMETRY EXPERIENCE
Nishit Gupta, Ravikiran Pawar, Sambhunath Banerjee, et al.
Mediterranean Journal of Hematology and Infectious Diseases (2019) Vol. 11, Iss. 1, pp. e2019017-e2019017
Open Access | Times Cited: 35
Applications and efficiency of flow cytometry for leukemia diagnostics
Maria Ilaria Del Principe, Eleonora De Bellis, Carmelo Gurnari, et al.
Expert Review of Molecular Diagnostics (2019) Vol. 19, Iss. 12, pp. 1089-1097
Closed Access | Times Cited: 30
Overview on Aneuploidy in Childhood B-Cell Acute Lymphoblastic Leukemia
Kinga Panuciak, Emilia Nowicka, Angelika Mastalerczyk, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8764-8764
Open Access | Times Cited: 10
Chemotherapy alters the increased numbers of myeloid-derived suppressor and regulatory T cells in children with acute lymphoblastic leukemia
Mohamed Labib Salem, Mohamed El‐Shanshory, Said Abdou, et al.
Immunopharmacology and Immunotoxicology (2018) Vol. 40, Iss. 2, pp. 158-167
Closed Access | Times Cited: 32
Drugging the unfolded protein response in acute leukemias
Behzad Kharabi Masouleh, Éric Chevet, Jens Panse, et al.
Journal of Hematology & Oncology (2015) Vol. 8, Iss. 1
Open Access | Times Cited: 29
PDX models reflect the proteome landscape of pediatric acute lymphoblastic leukemia but divert in select pathways
Anuli C. Uzozie, Enes K. Ergin, Nina Rolf, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 21
miR-324-3p and miR-508-5p expression levels could serve as potential diagnostic and multidrug-resistant biomarkers in childhood acute lymphoblastic leukemia
Atefeh Zamani, Nasrin Fattahi Dolatabadi, Massoud Houshmand, et al.
Leukemia Research (2021) Vol. 109, pp. 106643-106643
Closed Access | Times Cited: 21
Specific expression of novel long non-coding RNAs in high-hyperdiploid childhood acute lymphoblastic leukemia
Mathieu Lajoie, Simon Drouin, Maxime Caron, et al.
PLoS ONE (2017) Vol. 12, Iss. 3, pp. e0174124-e0174124
Open Access | Times Cited: 27
ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
Bieke Soen, Niels Vandamme, Geert Berx, et al.
HemaSphere (2018) Vol. 2, Iss. 3
Open Access | Times Cited: 27
MicroRNAs as biomarkers for graft-versus-host disease following allogeneic stem cell transplantation
Ciprian Tomuleasa, Shigeo Fuji, Andrei Cucuianu, et al.
Annals of Hematology (2015) Vol. 94, Iss. 7, pp. 1081-1092
Closed Access | Times Cited: 23
The pyrrolo-1,5-benzoxazepine, PBOX-15, enhances TRAIL-induced apoptosis by upregulation of DR5 and downregulation of core cell survival proteins in acute lymphoblastic leukaemia cells
Seema-Maria Nathwani, Lisa M. Greene, Stefania Butini, et al.
International Journal of Oncology (2016) Vol. 49, Iss. 1, pp. 74-88
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top